Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion type Assertion NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_head.
- NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion description "[In patients, with xeroderma pigmentosum the severity of clinical symptoms depends on the length of the XPA gene products.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_provenance.
- NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion evidence source_evidence_literature NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_provenance.
- NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion SIO_000772 12459522 NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_provenance.
- NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion wasDerivedFrom lhgdn-20090331 NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_provenance.
- NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_assertion wasGeneratedBy ECO_0000203 NP215992.RASwhQyQRErHGmVP4TF6M8CKV0lCQ6xAdUPaTSQ8tiQNY130_provenance.